Literature DB >> 12224786

Amiodarone distribution in human tissues after long-term therapy: a case of arrhythmogenic right ventricular cardiomyopathy.

Fumitaka Hosaka1, Tsuyoshi Shiga, Yasunari Sakomura, Michi Wakaumi, Naoki Matsuda, Hiroshi Kasanuki.   

Abstract

The tissue distribution of amiodarone and desethylamiodarone, its active metabolite, was examined in an autopsied case, an 85-year-old man, with arrhythmogenic right ventricular cardiomyopathy (ARVC) who had been receiving amiodarone for 4 years. High concentrations of amiodarone, a very highly lipophilic compound, were found in adipose and bone marrow tissues. Despite a low dose (100 mg daily), the concentrations of amiodarone were higher in the epicardial fat (570.4 microg/g) and in the right atrium (165.3 microg/g) than previously reported in patients with other cardiac diseases. The ratios of amiodarone/ desethylamiodarone concentrations in both tissues were >1. This unique distribution demonstrates the involvement of histological characteristics of ARVC, such as fatty replacement of myocardium. We anticipate that a low dose of amiodarone would be effective in preventing arrhythmia in some patients with ARVC.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12224786     DOI: 10.1007/s003800200012

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  1 in total

1.  Dysfunction of the thyroid gland during amiodarone therapy: a study of 297 cases.

Authors:  Agata Czarnywojtek; Maria Teresa Płazińska; Małgorzata Zgorzalewicz-Stachowiak; Kosma Woliński; Adam Stangierski; Izabela Miechowicz; Joanna Waligórska-Stachura; Paweł Gut; Leszek Królicki; Maja Zioncheck; Marek Ruchała
Journal:  Ther Clin Risk Manag       Date:  2016-04-04       Impact factor: 2.423

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.